SAN DIEGO, Aug. 19, 2025 ( GLOBE NEWSWIRE ) -- iBio, Inc. ( Nasdaq: IBIO ) , an AI-driven innovator of precision antibody therapies, today announced the pricing of an underwritten public offering ( the &#34;offering&#34; ) of ( i ) pre-funded warrants to purchase 71,540,000 shares of iBio's common stock ...

IBIO

<p>SAN DIEGO, Aug. 19, 2025 ( GLOBE NEWSWIRE ) -- iBio, Inc. ( Nasdaq: IBIO ) , an AI-driven innovator of precision antibody therapies, today announced the pricing of an underwritten public offering ( the "offering" ) of ( i ) pre-funded warrants to purchase 71,540,000 shares of iBio's common stock ...</p>

iBio 宣佈 5000 萬美元公開發行的定價